TP53 and glioblastoma: Intriguingly, our re-analyses of published bulk RNA-sequencing and CRISPR-screening datasets of neratinib-treated human SF268 glioblastoma cell line suggested that p53-dependent apoptosis, but not ferroptosis, was induced following 72 h of neratinib treatment (Fig. 2d and e).